估算瑞典斯德哥尔摩 2019 年冠状病毒病疫情期间的总超额死亡率。
Estimating Total Excess Mortality During a Coronavirus Disease 2019 Outbreak in Stockholm, Sweden.
机构信息
Department of Pathology, Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Department of Infectious Disease Control and Vaccination, Institute for Health and Welfare, Helsinki, Finland.
出版信息
Clin Infect Dis. 2021 Jun 1;72(11):e890-e892. doi: 10.1093/cid/ciaa1593.
Abstract
Total excess mortality peaked during a coronavirus disease 2019 (COVID-19) outbreak in Stockholm, but 25% of these deaths were not recognized as COVID-19 related nor occurred in hospitals. Estimate of total excess mortality may give a more comprehensive picture of the total disease burden during a COVID-19 outbreak, and may facilitate managing future outbreaks.
摘要
在斯德哥尔摩发生的 2019 冠状病毒病（COVID-19）疫情期间，总超额死亡率达到峰值，但其中 25%的死亡病例未被认定与 COVID-19 相关，也并非发生在医院。估计总超额死亡率可更全面地了解 COVID-19 疫情期间的总疾病负担情况，并有助于管理未来的疫情。
相似文献
1
Estimating Total Excess Mortality During a Coronavirus Disease 2019 Outbreak in Stockholm, Sweden.估算瑞典斯德哥尔摩 2019 年冠状病毒病疫情期间的总超额死亡率。
Clin Infect Dis. 2021 Jun 1;72(11):e890-e892. doi: 10.1093/cid/ciaa1593.
2
Severe features during outbreak but low mortality observed immediately before and after a March-May 2020 COVID-19 outbreak in Stockholm, Sweden.2020 年 3 月至 5 月期间，瑞典斯德哥尔摩发生了一起 COVID-19 疫情，在疫情爆发期间出现了严重的症状，但在疫情爆发前后的死亡率较低。
Int J Infect Dis. 2021 Sep;110:433-435. doi: 10.1016/j.ijid.2021.08.005. Epub 2021 Aug 8.
3
Mortality of the COVID-19 Outbreak in Sweden in Relation to Previous Severe Disease Outbreaks.与先前严重疾病暴发相关的瑞典 COVID-19 疫情死亡率。
Front Public Health. 2021 Feb 18;9:579948. doi: 10.3389/fpubh.2021.579948. eCollection 2021.
4
Management of the emergency response to the SARS-CoV-2 (COVID-19) outbreak in Stockholm, Sweden, and winter preparations.瑞典斯德哥尔摩应对严重急性呼吸综合征冠状病毒2（COVID-19）疫情的应急管理及冬季准备工作
J Prim Health Care. 2020 Sep;12(3):207-214. doi: 10.1071/HC20082.
5
Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.2020 年 3 月 11 日至 5 月 2 日期间 COVID-19 爆发期间超额死亡的初步估计-纽约市。
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):603-605. doi: 10.15585/mmwr.mm6919e5.
6
Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.养老院内 COVID-19 疫情的演变和影响：英国一个地理区域内 189 家养老院的人群分析。
Lancet Healthy Longev. 2020 Oct;1(1):e21-e31. doi: 10.1016/S2666-7568(20)30012-X. Epub 2020 Oct 20.
7
Excess mortality from COVID-19: weekly excess death rates by age and sex for Sweden and its most affected region.COVID-19 导致的超额死亡率：瑞典及其受影响最严重地区按年龄和性别划分的每周超额死亡率。
Eur J Public Health. 2021 Feb 1;31(1):17-22. doi: 10.1093/eurpub/ckaa218.
8
Mortality in Norway and Sweden during the COVID-19 pandemic 2020-22: A comparative study.2020-22 年新冠大流行期间挪威和瑞典的死亡率：一项比较研究。
J Infect Public Health. 2024 Apr;17(4):719-726. doi: 10.1016/j.jiph.2023.10.033. Epub 2023 Nov 3.
9
High excess mortality in areas with young and socially vulnerable populations during the COVID-19 outbreak in Stockholm Region, Sweden.在瑞典斯德哥尔摩地区 COVID-19 疫情期间，人口年轻且社会脆弱的地区死亡率过高。
BMJ Glob Health. 2020 Oct;5(10). doi: 10.1136/bmjgh-2020-003595.
10
Temporal dynamic in the impact of COVID- 19 outbreak on cause-specific mortality in Guangzhou, China.新冠疫情对中国广州特定病因死亡率影响的时间动态变化。
BMC Public Health. 2021 May 8;21(1):883. doi: 10.1186/s12889-021-10771-3.
引用本文的文献
1
Seroepidemiological assessment of the spread of SARS-CoV-2 among 25 and 28 year-old adult women in Finland between March 2020-June 2022.2020 年 3 月至 2022 年 6 月期间芬兰 25 至 28 岁成年女性中 SARS-CoV-2 传播的血清流行病学评估。
PLoS One. 2024 Jul 11;19(7):e0305285. doi: 10.1371/journal.pone.0305285. eCollection 2024.
2
Potential SARS-CoV-2 infectiousness among asymptomatic healthcare workers.无症状医护人员中的潜在 SARS-CoV-2 传染性。
PLoS One. 2021 Dec 17;16(12):e0260453. doi: 10.1371/journal.pone.0260453. eCollection 2021.
3
SARS-CoV-2 infections amongst personnel providing home care services for older persons in Stockholm, Sweden.瑞典斯德哥尔摩为老年人提供家庭护理服务人员中的 SARS-CoV-2 感染情况。
J Intern Med. 2021 Aug;290(2):430-436. doi: 10.1111/joim.13274. Epub 2021 Apr 12.
4
Antibodies to SARS-CoV-2 and risk of past or future sick leave.针对 SARS-CoV-2 的抗体与过去或未来请病假的风险。
Sci Rep. 2021 Mar 4;11(1):5160. doi: 10.1038/s41598-021-84356-w.
Zotero 插件